Vivos Therapeutics (VVOS) Gains from Investment Securities (2023)
Vivos Therapeutics (VVOS) posted quarterly Gains from Investment Securities of -$1.6 million for Q3 2023, down 284.54% quarter-over-quarter from $867000.0 in Q2 2023.
Vivos Therapeutics (VVOS) Gains from Investment Securities (2023) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Gains from Investment Securities for 1 consecutive years, with -$1.6 million the latest figure, recorded in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Vivos Therapeutics | 4.94 Mn | 3.14 Mn | 2.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -1.60 Mn |
| Sep 30, 2023 | -1.60 Mn |
| Jun 30, 2023 | 867,000.00 |
| Jun 30, 2023 | 867,000.00 |
| Mar 31, 2023 | -9.63 Mn |
| Mar 31, 2023 | -9.63 Mn |